Since paclitaxel and docetaxel have a high affinity for the ATP-dependent drug efflux pump P-glycoprotein (Pgp) [7], it is considered that Pgp expression by cancer cells can be responsible for resistance to taxanes. This evidence concerns the gene PGP and cancer.